We provide you with 20 years of free, institutional-grade data for NBY stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NBY. Explore the full financial landscape of NBY stock.
| Reported Date | CIK | Ticker | Type |
|---|
NovaBay Pharmaceuticals, Inc(NYSE MKT:NBY) 
NovaBay Pharmaceuticals, Inc., a medical device company, develops products for the eye care markets in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including t...
Website: http://www.novabay.com
Founded: 2000
Full Time Employees: 26
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about NBY stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.